05:51:47 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-30 Årsstämma 2024
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 Ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2023-12-15 Ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 Ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 Ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2023-02-14 17:52:15

Today on February 14, 2023, in Copenhagen - CS MEDICA A/S ("CS MEDICA" or the "Company") held its annual general meeting ("AGM") at which the following principal resolutions were passed.

1. Election of chairman of the meeting
The board proposed Rolf Lavigné Ussing as chairman of the meeting.  The proposal was accepted.

The chairman concluded that the Annual General Meeting (AGM) was announced in accordance with the Articles of Association section 5.1.  Notice of the AGM was sent in due time the 30th of January 2023.

The notice was in accordance with section 5.2.

The chairman ascertained that the number of voting shares was 8.122.174.  The total number of shares of the company amount to 12.322.635.

2. Presentation of the annual report with auditors' report for adoption
The AGM resolved in accordance with the Board of Directors' proposal, to approve the annual report presented during the AGM, with all votes represented at the AGM.

3. Resolution concerning the appropriation of profits or losses as recorded in the adopted annual report
The AGM resolved, in accordance with the Board of Directors' proposal, that the result for the period 1 October 2020 - 30 September 2021 (DKK -10.802.971 ) is carried forward to the following year, with all votes represented at the AGM..

4. Election of members to the board of directors
The AGM resolved, in accordance with the Board of Directors' proposal, that the Board members, were re-elected, except Stein Lokstad who resign from the board.  The decision was supported by all votes represented at the AGM.

5. Election of auditor
The AGM resolved, in accordance with the board of directors' proposal, that the existing auditor Christensen Kjærulff Statsautoriseret Revisionsaktieselskab was re-elected. The decision was supported by all votes represented at the AGM.

6. Authorization for the board of directors to issue incentive warrants up to 5% of the current share capital
The AGM resolved, in accordance with the board of directors' proposal, and authorises the board of directors to issue warrants to the Company's board of directors, executive management and ordinary employees. The authorization shall be valid for a period of 5 years from the date of the extraordinary general meeting. The board of directors shall be authorized to issue warrants corresponding to nominally DKK 40,040 shares (which is equal to approx. 5% of the Company's current share capital). The autorisation will be adopted in the Company's articles of association.

The decision was supported by all votes represented at the AGM.

7. Change of the financial year to the calendar year
The AGM resolved, in accordance with the board of directors' proposal, that the Company's financial year (October 1 - September 30) is changed to the calender year. The conversion period will be from 1 October 2023 to 31 December 2023. The Company's articles of association will be amended accordingly.

The decision was supported by all votes represented at the AGM.

8. Any other business
The Chairman ascertained that no other business was to be dicussed.

This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528) and the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 14-02-2023 17:52 CET.